MSL
VIR icon

Mackay Shields LLC’s Vir Biotechnology VIR Stock Holding History

Mackay Shields LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,900
Closed -$1.28M – 1316
2021
Q1 		$1.28M Sell
24,900
-18,000
-42% -$970K 0.01% 928
2020
Q4 		$1.15M Buy
42,900
+8,200
+24% +$267K 0.01% 1048
2020
Q3 		$1.19M Buy
+34,700
New +$1.49M 0.01% 970

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Mackay Shields LLC's VIR Position: Q2 2021 in Review

Mackay Shields LLC sold out of Vir Biotechnology (VIR) in Q2 2021, closing a stake of 24,900 shares — an estimated $1.28M sold.

Mackay Shields LLC first reported a position in VIR in Q3 2020 and held it in 3 quarters. The position peaked at $1.28M in Q1 2021. 166 funds tracked by Wall St. Rank hold VIR as of Q2 2021.

  • Mackay Shields LLC reported no remaining Vir Biotechnology position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 24,900 Vir Biotechnology shares in Q2 2021, an estimated $1.28M.
  • Mackay Shields LLC first reported a position in Vir Biotechnology in Q3 2020 and held it in 3 quarters.
  • Mackay Shields LLC's Vir Biotechnology position peaked at $1.28M in Q1 2021.
  • 166 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.